eriocitrin has been researched along with Cancer of Liver in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Fan, X; Gan, C; Qi, S; Qi, Z; Zhang, Y; Zhou, H | 1 |
Chen, K; Chen, L; Huang, Z; Wang, Z; Zhang, H; Zhang, X; Zhou, J | 1 |
2 other study(ies) available for eriocitrin and Cancer of Liver
Article | Year |
---|---|
[Eriocitrin suppresses proliferation and migration of hepatocellular carcinoma SMMC-7721 cells by promoting ROS production and activating the MAPK pathway].
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Humans; Liver Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Poly(ADP-ribose) Polymerase Inhibitors; Reactive Oxygen Species | 2023 |
Eriocitrin from lemon suppresses the proliferation of human hepatocellular carcinoma cells through inducing apoptosis and arresting cell cycle.
Topics: Activating Transcription Factor 1; Apoptosis; Carcinoma, Hepatocellular; Caspases; Cell Cycle Checkpoints; Cell Proliferation; Cell Transformation, Neoplastic; Citrus; Cyclic AMP Response Element-Binding Protein; Flavanones; Hep G2 Cells; Humans; Liver Neoplasms; MAP Kinase Signaling System; Phosphorylation | 2016 |